Skip to content
The wire
Wall Street
ASXASX 200 9,082.20 down -0.71%as at 13 Nov 2026, 3:29 pm GMT+0800BHP Group (BHP) 58.86 AUD down -1.26%as at 13 Nov 2026, 3:29 pm GMT+0800Commonwealth Bank (CBA) 170.87 AUD down -0.52%as at 13 Nov 2026, 3:29 pm GMT+0800CommoditiesBrent Crude Oil (Brent Futures) 95.84 USD/bbl up +0.02%as at 15 Nov 2026, 6:08 am GMT+0800WTI Crude Oil (WTI Futures) 88.56 USD/bbl down -0.20%as at 15 Nov 2026, 6:08 am GMT+0800EuronextCAC 40 8,368.91 up +0.09%as at 15 Nov 2026, 6:08 am GMT+0800Euro StoxxEURO STOXX 50 6,386.86 down -0.19%as at 15 Nov 2026, 6:08 am GMT+0800FTSEFTSE 100 10,902.56 up +0.36%as at 14 Nov 2026, 5:52 am GMT+0800HKEXHANG SENG 23,637.60 down -1.55%as at 14 Nov 2026, 5:52 am GMT+0800NasdaqAlphabet (GOOGL) 295.77 USD down -0.98%as at 14 Nov 2026, 5:52 am GMT+0800Amazon (AMZN) 266.66 USD down -0.29%as at 14 Nov 2026, 5:52 am GMT+0800Apple (AAPL) 356.27 USD up +0.39%as at 14 Nov 2026, 5:52 am GMT+0800DOW JONES 52,347.55 up +0.10%as at 14 Nov 2026, 5:52 am GMT+0800Meta Platforms (META) 641.69 USD up +2.90%as at 14 Nov 2026, 5:52 am GMT+0800NASDAQ 25,136.27 down -0.91%as at 14 Nov 2026, 5:52 am GMT+0800S&P 500 7,561.67 down -0.40%as at 14 Nov 2026, 5:52 am GMT+0800Tesla (TSLA) 390.22 USD down -1.82%as at 14 Nov 2026, 5:52 am GMT+0800NSENIFTY 50 25,299.35 up +0.18%as at 13 Nov 2026, 3:29 pm GMT+0800NYSEBerkshire Hathaway (BRK.B) 592.94 USD up +0.53%as at 14 Nov 2026, 5:52 am GMT+0800NZXNZX 50 14,303.77 up +0.92%as at 16 Nov 2026, 1:53 pm GMT+0800Russell 2000RUSSELL 2000 2,790.49 down -0.31%as at 14 Nov 2026, 5:52 am GMT+0800SSESHANGHAI COMPOSITE 3,634.35 down -0.59%as at 16 Nov 2026, 1:53 pm GMT+0800TSENIKKEI 225 61,142.35 up +0.53%as at 13 Nov 2026, 3:29 pm GMT+0800XetraDAX 40 26,749.95 down -0.08%as at 15 Nov 2026, 6:08 am GMT+0800CryptoBTC/USD 68,241.00 USD down -4.59%as at 14 Nov 2026, 5:52 am GMT+0800Ethereum (ETH/USD) 1,926.53 USD down -4.56%as at 14 Nov 2026, 5:52 am GMT+0800SOL/USD 78.830 USD down -3.22%as at 14 Nov 2026, 5:52 am GMT+0800XRP/USD 1.01000 USD down -2.63%as at 14 Nov 2026, 5:52 am GMT+0800ForexAUD/EUR 0.613500 EUR down -0.29%as at 16 Nov 2026, 1:53 pm GMT+0800AUD/GBP 0.511800 GBP down -0.47%as at 16 Nov 2026, 1:53 pm GMT+0800AUD/JPY 107.8800 JPY down -0.85%as at 16 Nov 2026, 1:53 pm GMT+0800AUD/NZD 1.224200 NZD down -0.25%as at 16 Nov 2026, 1:53 pm GMT+0800AUD/USD 0.675900 USD down -0.66%as at 16 Nov 2026, 1:53 pm GMT+0800EUR/GBP 0.834230 GBP down -0.17%as at 16 Nov 2026, 1:53 pm GMT+0800EUR/USD 1.101712 USD down -0.37%as at 16 Nov 2026, 1:53 pm GMT+0800GBP/USD 1.320633 USD down -0.20%as at 16 Nov 2026, 1:53 pm GMT+0800NZD/USD 0.552116 USD down -0.41%as at 16 Nov 2026, 1:53 pm GMT+0800USD/CAD 1.427874 CAD up +0.15%as at 16 Nov 2026, 1:53 pm GMT+0800USD/CHF 0.839177 CHF up +0.47%as at 16 Nov 2026, 1:53 pm GMT+0800USD/CNY 6.670957 CNY up +0.02%as at 16 Nov 2026, 1:53 pm GMT+0800USD/JPY 159.6089 JPY down -0.19%as at 16 Nov 2026, 1:53 pm GMT+0800
Rates
  • UKUK jobless4.7%Out in 17 h 44 min
  • AURBA4.85%Next 8 Dec
  • USFed3.75-4.00%Next 10 Dec
  • UKBoE4.00%Next 17 Dec
  • EUECB2.50%Next 17 Dec
  • JPBoJ1.25%Next 18 Dec
  • CABoC2.50%Next 9 Dec
  • NZRBNZ2.75%Next 9 Dec
  • USUS CPI+0.4% m/mOct
  • USPayrolls+165,000 jobsOct 2026, seasonally adjusted monthly payroll change
  • USUS jobless4.1%Oct 2026, seasonally adjusted unemployment rate
  • USCore PCE3.1% y/ySep 2026, core PCE price index y/y
  • USUS GDP+3.4% annualisedQ3 2026, q/q seasonally adjusted annual rate
  • USUS retail+0.8% m/mSep 2026, m/m retail sales, seasonally adjusted
  • USISM mfg55.5Oct 2026, ISM manufacturing PMI index points
  • AUAU CPI4.3% y/ySep 2026, CPI y/y
  • AUAU jobless4.7%Sep 2026, seasonally adjusted unemployment
  • AUAU GDP+0.4% q/qQ2 2026, seasonally adjusted real GDP q/q
  • UKUK CPI3.5% y/ySep 2026, 12-month CPI
  • UKUK GDP+0.7% q/qQ3 2026, real GDP q/q
  • EUEZ CPI4.0% y/yOct 2026 euro-area HICP, flash estimate
  • CNChina GDP4.5% y/yQ3 2026, real GDP y/y
  • XAUGold4,052.40 USD/oz-1.49%
  • OILBrent99.69 USD/bbl+1.42%
  • OILWTI91.36 USD/bbl+0.11%
  • USUS 10Y4.837%-0.057 pts
  • VIXVIX28.18+69.66%
  • USDDXY101.768+0.21%
  • BTCBitcoin75,551.00 USD-6.09%
Monday 16 November 2026A wider view Independent in spirit. Open by design.

The headline.
The whole story.

Live desk
On the agenda Israel electionIran warPhuket fireD. Jones shootingAlaska Senate countNvidia fallout
BreakingPuberty blockers Australia 2 min read

Puberty blockers should stay on the table for some trans teens, national advice says, and two governments that banned them now have to answer

Australia's first national advice on puberty blockers says they should remain a clinical option for some trans and gender diverse young people who have started puberty, even though the evidence behind them is low certainty. The interim advice, opened for public comment at 1pm AEDT today, lands directly on Queensland and the Northern Territory, which have banned or restricted the drugs in their public systems. Within hours, both said their positions had not changed.

Valcored News Network © Valcored News. All rights reserved.

Live updates

Times in GMT+0800
  1. Monday afternoon AWSTLatest

    Queensland Health Minister Tim Nicholls says the state's position is unchanged after its own independent review. A Northern Territory government spokesperson says the NT's position is also unchanged.

  2. 11.10am AWST

    No public response yet from the Queensland or Northern Territory governments.

  3. 10am AWST

    The NHMRC releases its interim advice on puberty suppressants for public consultation, open until 1pm AEDT on 18 January 2027.

This page checks for new updates automatically.

Three things to know

  1. The recommendation is "conditional": blockers could be considered after shared decisions between the young person, their carers and clinicians, not offered as routine.
  2. Reviewers found 15 non-randomised studies, most following patients for six months to two years, and rated the overall certainty of evidence as low.
  3. The advice is not binding, and Queensland and the Northern Territory have already said they will not change course. The full national guidelines are not due until late 2028.

The National Health and Medical Research Council’s interim advice on puberty suppressants for people under 18 was released for public consultation at 1pm AEDT (10am AWST) on Monday. Comments close at 1pm AEDT on 18 January 2027.

The advice was drawn up by the NHMRC’s Gender Guidelines Development Committee. It makes a conditional recommendation in favour of the drugs, known as GnRH analogues, for certain young people: those with gender incongruence, with or without distress, who have been assessed as suitable for treatment and have begun puberty.

A conditional recommendation means the benefits are judged likely to outweigh the harms, but the right choice depends on the individual. The committee said both triggers for that grading applied here: shared decision-making is essential, and the evidence is weak.

What did the evidence show?

The reviewers found the drugs may improve psychosocial functioning and may reduce suicidal behaviours. They found no eligible evidence either way on fertility, fractures or bone health. Serious adverse events were rare, the advice says, but young people on the medication should be monitored.

Why does it matter to Queensland and the NT?

Queensland paused new prescriptions of puberty blockers in its public system in January 2025 and, after a review, said in December 2025 the pause would continue until a UK clinical trial finishes, which is not expected until 2031. The Northern Territory has banned the drugs for under-18s in its public system.

The advice left both governments to decide whether to keep those restrictions. By Monday afternoon both had answered: no change.

Queensland Health Minister Tim Nicholls said the government had already held an independent review and “made a clear decision” on the treatments in public hospitals. “Our position remains unchanged,” he said. A Northern Territory government spokesperson said its position was also unchanged.

That sets the states against the national body for now. Federal Health Minister Mark Butler, who asked the NHMRC in 2025 to write the guidelines with priority advice on blockers, has said he expects the states to give the advice proper consideration.

Why is this so contested?

Supporters argue pausing puberty buys time for young people and their families. Critics say the treatment is experimental and that low-certainty evidence demands greater caution. The United Kingdom, Finland and many US states have moved to restrict use.

VNN will update this story as more is confirmed.

If this story raises concerns for you, support is available from Lifeline on 13 11 14, Beyond Blue on 1300 22 4636, QLife on 1800 184 527, or 13YARN on 13 92 76 for Aboriginal and Torres Strait Islander people.

How we got here

The key moments that brought this story into focus. Open any moment for detail.

  1. January 2025Queensland pauses puberty blockers

    New public-system prescriptions for under-18s are halted pending a review.

  2. 2025Butler orders national guidelines

    The Health Minister asks the NHMRC for guidelines on trans and gender diverse young people, with priority advice on blockers.

  3. December 2025Queensland extends its pause

    The state says it will hold the line until a UK trial ends, expected in 2031.

  4. 16 November 2026National interim advice released

    The NHMRC backs blockers as a conditional option and opens consultation.

  5. 16 November 2026Queensland and NT hold firm

    Both governments say their positions are unchanged.

What happens next

Public consultation runs until 1pm AEDT on 18 January 2027. The NHMRC expects the full guidelines to go out for consultation by early 2028 and to be issued in late 2028. Queensland and the Northern Territory say they will keep their restrictions; Queensland's pause is set to run until 2031 unless the government changes it.

Sources

  • VNN

VNN never names people who give us information in confidence. How we protect sources and tips.

The headline. The whole story.

Spotted something we should check? Tell the newsroom.

Comments

0 comments

Community rules

To read and join the conversation, please agree to our rules.

  1. Be respectful. No insults, name-calling, harassment, threats or hate.
  2. No links, web addresses or email addresses of any kind.
  3. No spam, advertising or self-promotion.
  4. One comment per story. You can reply to other people's comments, and to replies on yours.
  5. Stay on topic and keep personal information private.
  6. Comments that break these rules are removed, and repeat offenders are blocked.

Accessibility

Change how this website looks and behaves for you. Your choices are saved in this browser on this device only.

Text

Text size100%

Colour and links

Movement and focus

Read and find your way

Jump to a section of this page

    Your browser and device also have accessibility settings, such as zoom (Ctrl or ⌘ and +), a screen reader and reduced motion. This website works with them.

    Your privacy choices

    We use cookies and similar technologies to run this website. With your permission, we would also use them for advertising and embedded videos and social media posts. You can change your mind at any time with “Cookie settings” at the bottom of every page. Cookies policy.

    Cookie settings

    Choose what you allow. Storage the website needs to work is always on. You can come back here at any time from “Cookie settings” at the bottom of every page.

    • Strictly necessary

      Security, signing in, payments you start, protection against ad fraud and remembering your cookie choice.

      Always on
      What is stored (10)
      • vnn_consent VNN (this website) · Cookie · 12 months
        Remembers your cookie choices so we do not ask on every page.
      • wordpress_logged_in_*, wordpress_sec_* WordPress (this website) · Cookie · Until you sign out, up to 14 days
        Keeps you signed in, if you have an account (VNN staff, subscribers and buyers).
      • wordpress_test_cookie WordPress (this website) · Cookie · Until you close the browser
        Checks your browser accepts cookies when you sign in.
      • wp-settings-*, wp-settings-time-* WordPress (this website) · Cookie · 1 year
        Remembers dashboard layout for VNN staff. Not set for readers.
      • vcn_co VNN (this website) · Cookie · 1 day
        Links a payment to the browser that made it, so a new reader is signed in straight away after paying.
      • vnn_rules VNN (this website) · Cookie · 1 year
        Remembers that you agreed to the community rules before commenting.
      • vnn.rules VNN (this website) · Local storage · Until you clear your browser data
        The same agreement, kept in your browser as a back-up.
      • vnn.adshield.block, vnn.adshield.clicks VNN (this website) · Local storage · Up to 24 hours
        Protects our advertisers from invalid clicks (ad fraud) by pausing ads after repeated clicks.
      • vnn.adshield.ok VNN (this website) · Session storage · Until you close the tab
        Avoids re-checking the click protection on every page.
      • Payment security cookies Our card payment processor · Cookie · Up to 1 year
        Set only on the payment page and the billing part of your account page, to protect card payments from fraud.
    • Your settings on this device

      Saved stories, followed topics and other settings you choose. Kept in your browser only.

      Always on
      What is stored (7)
      • vcn.saved-stories.v1 VNN (this website) · Local storage · Until you remove them
        The stories you save with the bookmark button.
      • vcn.followed-topics.v1 VNN (this website) · Local storage · Until you remove them
        The topics you choose to follow.
      • vnn.alert.dismissed VNN (this website) · Session storage · Until you close the tab
        Remembers that you closed the breaking-news bar.
      • vnn.access VNN (this website) · Local storage · Until you reset them
        Your accessibility settings, such as text size and contrast.
      • vnn.support VNN (this website) · Local storage · Until you clear your browser data
        Remembers when you closed the “Support VNN” panel or gave, so it does not keep appearing.
      • comment_author_*, comment_author_email_* WordPress (this website) · Cookie · About 1 year
        Fills in your name and email on the comment form, only if you tick “Save my name”.
      • vnn-app-* VNN (this website) · Cache storage (service worker) · Until the app updates or you clear site data
        The web app’s icons and offline page, so it opens quickly and can tell you when you are offline.
    • Advertising

      Lets our advertising partner show ads based on your interests and measure them. If you say no, you may still see ads, but they are not personalised.

      What is stored (1)
      • __gads, __gpi, __eoi and Google ad cookies (e.g. IDE on doubleclick.net) Google AdSense · Cookie · Up to 13 months (set by Google)
        Shows ads, limits how often you see the same ad, prevents fraud and measures results. Ads are personalised only if you accept advertising.
    • Embedded videos and posts

      Loads videos, social media posts and other content hosted by other companies, such as YouTube or X. They may set their own cookies. If you say no, each one waits until you choose to load it.

      What is stored (1)
      • Set by the provider YouTube, Vimeo, X (Twitter), Instagram, TikTok, Facebook, Spotify and other embedded services · Cookie · Set by the provider
        Plays videos and shows posts inside our stories. Nothing loads until you choose to load it or allow embedded content.

    Full details: Cookies policy.

    VNNVALCORED NEWS NETWORK

    Install the VNN web app

    Choose your device to see how to add VNN to your home screen.

      What is the VNN web app?

      It is this website, saved to your home screen so it opens like an app: full screen, one tap away, straight to the front page. It is free, there is no app store download, it uses almost no storage and it updates itself. To remove it, press and hold the VNN icon and choose Remove. What the web app stores on your device